Vext Science, Inc. (VEXTF)
OTCMKTS · Delayed Price · Currency is USD
0.2350
+0.0124 (5.57%)
Sep 10, 2025, 12:46 PM EDT
Vext Science Revenue
Vext Science had revenue of $13.41M in the quarter ending June 30, 2025, with 59.10% growth. This brings the company's revenue in the last twelve months to $44.15M, up 32.45% year-over-year. In the year 2024, Vext Science had annual revenue of $36.00M with 3.40% growth.
Revenue (ttm)
44.15M
Revenue Growth
+32.45%
P/S Ratio
1.26
Revenue / Employee
n/a
Employees
n/a
Market Cap
55.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36.00M | 1.19M | 3.40% |
| Dec 31, 2023 | 34.81M | -598.33K | -1.69% |
| Dec 31, 2022 | 35.41M | -1.83M | -4.92% |
| Dec 31, 2021 | 37.24M | 12.05M | 47.83% |
| Dec 31, 2020 | 25.19M | 2.87M | 12.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
Vext Science News
- 21 days ago - Vext Science Inc. (VEXTF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Vext Announces Q2 2025 Financial Results: Record Quarterly Revenue with Strong 31% Cash Flow Margin - Newsfile Corp
- 4 weeks ago - Vext to Announce Financial Results for Q2 2025 on August 20, 2025 - Newsfile Corp
- 2 months ago - Vext Continues Ohio Expansion with Sixth Dispensary Location in Fairfield - Newsfile Corp
- 3 months ago - Vext Opens Fifth Ohio Dispensary in Portsmouth, Growing Retail Footprint in Key Ohio Market - Newsfile Corp
- 3 months ago - Vext Announces Change of Auditor - Newsfile Corp
- 4 months ago - Vext Science, Inc. (VEXTF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Vext Delivers Record Q1 Performance: Achieves $3.1 Million in Operating Cash Flow on $11.6 Million in Revenue - Newsfile Corp